Locations:
Search IconSearch

Making the Public Case for Prioritizing Transport to Comprehensive Stroke Centers

Trauma offers the ideal model, says Cleveland Clinic neurosurgeon

Emergency_650x450

For patient triage and transport, let’s treat stroke like trauma.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

That’s the argument made by Mark Bain, MD, a neurosurgeon with Cleveland Clinic’s Cerebrovascular Center, in a recent opinion piece published by The Columbus Dispatch, the leading newspaper in Ohio’s capital city.

Dr. Bain cites the model of Level 1 trauma centers adopted by states and localities decades ago as a blueprint for how states should handle policy around emergency medical transport of patients with suspected stroke to the most appropriate care centers.

He argues that hospital designations and EMS protocols should be changed to facilitate transport of these patients directly to a Joint Commission-certified Comprehensive Stroke Center, whenever possible, rather than simply the nearest hospital.

While Dr. Bain’s article was prompted by consideration of specific legislation in Ohio, he notes that the vast majority of U.S. states currently have no EMS protocols for routing stroke patients to Comprehensive Stroke Centers.

If you practice in one of those states and want a model for how to effectively frame this argument for the general public in your community, check out Dr. Bain’s opinion article here.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad